2-169646163-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001085447.2(CFAP210):c.1337C>A(p.Ala446Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000622 in 1,607,606 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001085447.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFAP210 | NM_001085447.2 | c.1337C>A | p.Ala446Glu | missense_variant | 9/9 | ENST00000447353.6 | NP_001078916.1 | |
CFAP210 | XM_047443326.1 | c.1265C>A | p.Ala422Glu | missense_variant | 10/10 | XP_047299282.1 | ||
CFAP210 | XM_011510590.2 | c.1094C>A | p.Ala365Glu | missense_variant | 9/9 | XP_011508892.1 | ||
CFAP210 | XM_047443327.1 | c.1040C>A | p.Ala347Glu | missense_variant | 8/8 | XP_047299283.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFAP210 | ENST00000447353.6 | c.1337C>A | p.Ala446Glu | missense_variant | 9/9 | 1 | NM_001085447.2 | ENSP00000391504 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152004Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000138 AC: 34AN: 245992Hom.: 0 AF XY: 0.000127 AC XY: 17AN XY: 133676
GnomAD4 exome AF: 0.0000605 AC: 88AN: 1455602Hom.: 0 Cov.: 32 AF XY: 0.0000677 AC XY: 49AN XY: 723416
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152004Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74230
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 02, 2023 | The c.1337C>A (p.A446E) alteration is located in exon 9 (coding exon 9) of the CCDC173 gene. This alteration results from a C to A substitution at nucleotide position 1337, causing the alanine (A) at amino acid position 446 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at